Hydroxychloroquine’s coronavirus trials to resume: WHO
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
The World Health Organization announced on June 4 that clinical trials of the drug hydroxychloroquine will resume as it searches for potential coronavirus treatments.

• On May 25, the WHO announced it had temporarily suspended the trials to conduct a safety review, which has now concluded there is “no reason” to change the way the trials are conducted.

• The UN health agency’s decision came after a study published in The Lancet medical journal suggesting the drug could increase the risk of death among COVID-19 patients.

• “Last week, the executive group of the Solidarity Trial decided to implement a temporary pause of the hydroxychloroquine arm of the trial, because of concerns raised about the safety of the drug,” WHO chief Tedros Adhanom Ghebreyesus told a virtual news briefing.

• “On the basis of the available mortality data, the members of the committee recommended that there are no reasons to modify the trial protocol."

• “The data safety and monitoring committee will continue to closely monitor the safety of all therapeutics being tested in the Solidarity Trial.”

More than 3,500 patients have been recruited across 35 countries to take part in the trials.

Source: https://www.hindustantimes.com/world-news/who-says-anti-malaria-drug-hydroxychloroquine-s-coronavirus-trials-to-resume/story-Frh9Hik3vPMXPXNEugUpFI.html
A●●●●●●i S●●●●●●a and 3 others like this1 share
Like
Comment
Share
Dr. S●●●●●m S●●●●y P●●●●●l
Dr. S●●●●●m S●●●●y P●●●●●l General Medicine
This is serious news. In another series of HCQ ping pong,this is episode 5. Now WHO will conduct another trial after NEJM and Lancet gave HCQ thumbs down,while ICMR says Thumbs up. WHO earlier did not want HCQ,but will conduct a fresh trial now. This is really interesting now. The question is no longer about the drug,it is now about the reliability and trustworthiness of even the apex and standard decision making bodies. I look forward to episode 6 of HCQ ping pong.... Read more
Jun 4, 2020Like1
Dr. N●●●●a G●●●a
Dr. N●●●●a G●●●a Obstetrics and Gynaecology
Underlying reason behind this ping pong is small studies, short time, fast travelling news with litigations and prestigue issues coming in the way. World has become morevocal then focal.
Jun 4, 2020Like